HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $611,200 | +61.4% | 16,000 | +52.4% | 0.01% | +50.0% |
| Q2 2023 | $378,735 | -95.3% | 10,500 | -95.0% | 0.00% | -95.2% |
| Q1 2023 | $8,019,900 | -33.0% | 210,000 | -0.2% | 0.08% | -33.6% |
| Q4 2022 | $11,977,450 | +1151.7% | 210,500 | +769.8% | 0.12% | +1036.4% |
| Q3 2022 | $956,868 | -27.3% | 24,200 | -26.7% | 0.01% | -8.3% |
| Q1 2022 | $1,316,000 | +1.3% | 33,000 | +2.2% | 0.01% | +33.3% |
| Q4 2021 | $1,299,000 | +46.4% | 32,300 | +48.2% | 0.01% | 0.0% |
| Q3 2021 | $887,000 | +226.1% | 21,800 | +263.3% | 0.01% | +200.0% |
| Q2 2021 | $272,000 | -70.3% | 6,000 | -72.7% | 0.00% | -66.7% |
| Q1 2021 | $917,000 | -50.5% | 22,000 | -49.3% | 0.01% | -52.6% |
| Q4 2020 | $1,854,000 | +63.6% | 43,400 | +0.7% | 0.02% | +46.2% |
| Q3 2020 | $1,133,000 | -30.3% | 43,100 | -28.9% | 0.01% | -31.6% |
| Q2 2020 | $1,625,000 | +148.1% | 60,600 | +66.5% | 0.02% | +111.1% |
| Q1 2020 | $655,000 | +29.2% | 36,400 | -8.8% | 0.01% | -10.0% |
| Q1 2014 | $507,000 | +40.8% | 39,900 | +66.2% | 0.01% | +42.9% |
| Q4 2013 | $360,000 | – | 24,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |